Next-Gen Drugs for Immunotherapy : Market Forecast, Transformation, and Long-Term Trajectories
Discover trends, market shifts, and competitive outlooks for the drugs for immunotherapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Are the Projected Market Size and Growth Rates for the Drugs for Immunotherapy Market From 2025 To 2029?#_x000D_
In recent times, the market size for immunotherapy drugs has experienced a swift expansion. Projected to escalate from $255.14 billion in 2024 to $281.43 billion in 2025, it is set to achieve a compound annual growth rate (CAGR) of 10.3%. Factors fuelling this growth during the historic period include an increased prevalence of cancer, unfulfilled medical requirements, greater awareness of cancer immunotherapy, higher adoption rates of immunotherapeutic strategies, and a surge in investments from major pharmaceutical entities._x000D_
_x000D_
The immunotherapy drugs market is anticipated to experience fast expansion in the upcoming years, with a projected value of $445.12 billion in 2029, showing a Compound Annual Growth Rate (CAGR) of 12.1%. The substantial growth forecasted for this period can be traced back to factors such as combination therapies, personalized medications, worldwide expansion, therapies driven by biomarkers, and the rise in clinical trials. Notable trends anticipated in the forecast period entail progress in immunology, advancements in car-t cell therapies, specific immunotherapies, combinations of immunotherapy, and neoantigen vaccines._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp_x000D_
_x000D_
#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Drugs for Immunotherapy Market?#_x000D_
The immunotherapy drugs market’s growth is primarily fuelled by the increasing global cancer rates. Various factors contribute to most cancer cases, such as obesity, smoking, alcohol consumption, and unhealthy dietary practices. As per the estimates of Macmillan Cancer Support, the largest healthcare charity in the UK, cancer cases are set to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. The most common types of cancer include breast, lung, colon, rectal, and prostate cancer. Approximately one-third of cancer deaths can be attributed to tobacco usage, a high body mass index, alcohol consumption, a diet lacking in fruits and vegetables, and lack of physical activity. It is anticipated that the surge in cancer occurrences will augment the need for immunotherapy drugs, hence, amplifying the growth of the immunotherapy drugs market._x000D_
_x000D_
#Which Key Market Segments Comprise the Drugs for Immunotherapy Market and Drive Its Revenue Growth?#_x000D_
The drugs for immunotherapy market covered in this report is segmented –_x000D_
_x000D_
1) By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types_x000D_
2) By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas_x000D_
3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies_x000D_
2) By Interferons: Interferon Alfa, Interferon Beta, Interferon Gamma_x000D_
3) By Interleukins: Interleukin-2 (IL-2), Interleukin-6 (IL-6), Interleukin-12 (IL-12)_x000D_
4) By Vaccines: Preventive Vaccines, Therapeutic Vaccines_x000D_
5) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors_x000D_
6) By Other Types: Cancer Cell Therapies, Cytokine Therapy, T-Cell Receptor Therapy_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=2559&type=smp_x000D_
_x000D_
#Which Areas Are Leading Regions in the Drugs for Immunotherapy Market Expansion Across the Globe?#_x000D_
The countries covered in the drugs for immunotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada._x000D_
_x000D_
#What Are the Key Market Trends in the Drugs for Immunotherapy Market Over the Coming Years?#_x000D_
Companies that are prominent in the immunotherapy drug market are concentrating on the development of new products, such as Keytruda (pembrolizumab), to deliver dependable services to their clients. Keytruda is a notable immunotherapy, supported with a targeted treatment drug classified as an immune checkpoint inhibitor, primarily prescribed to adult patients. Merck & Co., Inc., a US-based pharmaceutical firm, launched Keytruda (pembrolizumab) in January 2023, post its approval from the US Food and Drug Administration. The drug assists the immune system in combating cancer cells, aiding the treatment of various cancer types. It has also received approval as a supportive therapy for non-small cell lung cancer (NSCLC). This significant breakthrough in cancer care is projected to positively affect the healthcare sector._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#How Is the Drugs for Immunotherapy Market Conceptually Defined?#_x000D_
Drugs for immunotherapy refer to a kind of medication that offers treatment to either stimulate or suppress the immune system to aid the body’s protection against cancer, infection, and other disorders. Your immune system is assisted in fighting cancer via immunotherapy, a sort of cancer treatment. The body’s immune system aids in the fight against infections and other disorders._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2559_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
